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Biotechnology is an example of a horizontal enabling technology (Ministry for Economic 
Development, 2003), a technology with wide application across many businesses and 
industries that underpins a number of specific innovations. Developments in 
biotechnology – the use of biological systems, living organisms or parts of them to make 
or modify products or processes (Organisation for Economic Co-operation and 
Development, 2005) – have contributed significantly to New Zealand’s primary sector. 
Key examples of biotechnology developed in New Zealand for the primary industry 
include marker assisted breeding to combat footrot in sheep, clonal propagation of pine 
trees, soil additives to reduce nitrate leaching into rivers and lakes, and vaccines which 
increase lambing yield.  
The New Zealand economy is strongly reliant on its primary sector. The agribusiness 
and forestry sectors contribute an estimated 20 per cent of real GDP, 65 percent of 
merchandise exports, and around 47 per cent of total exports (Ministry of Agriculture and 
Forestry, 2004; Ministry of Fisheries, 2004; Statistics New Zealand, 2004). Thus, 
governmental policy towards biotechnology can have significant impacts on New 
Zealand trade and growth. 
In considering the effects of biotechnology on production, the potential for impacts 
from international price shifts needs to be analysed. New Zealand is an open economy, so 
the shifts in international commodity prices are transmitted directly to the farmgate 
(Kaye-Blake et al., 2003; Ministry of Agriculture and Forestry, 2004). Much of New 
Zealand’s primary production is exported (about 95% in the case of dairy products 
(Ministry of Agriculture and Forestry, 2004)), again suggesting that international 
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commodity prices are significant for farmgate prices. Finally, New Zealand represents a 
significant portion of world trade in some agricultural commodities, suggesting that its 
productivity might affect world prices.  
This paper presents an analysis of the potential impacts of biotechnology-derived 
productivity on New Zealand producer prices and thus on farmgate returns. The data on 
productivity impacts are disaggregated at the commodity level, which allows a detailed 
analysis of the differential impacts across the primary sector. The paper is organised in 
the following way. The next section reviews prior literature on biotechnology impacts 
and on trade modelling. The modelling section discusses the partial equilibrium model 
used and the data used to inform the current modelling. There follow sections containing 
the results of the modelling, discussion of the results, and concluding comments. 
 
Prior Literature 
There is an extensive literature on the trade impacts of biotechnology (for example, 
Anderson and Jackson, 2005; Frisvold et al., 2003; Lapan and Moschini, 2002; Qaim and 
Traxler, 2005; Saunders and Cagatay, 2003; Stone et al., 2002). Trade analyses have 
focused largely on genetically modified crops (but see Frisvold, et al. (2003)), and in 
particular on specific crops rather than the generalised value of the underlying 
biotechnology. They are useful for the present research for their findings regarding 
impacts of productivity gains and consumer willingness to pay for enhanced agricultural 
products. They also provide indications of robust methodologies for estimating trade 
impacts. 
  3 
Trade analysis has found that changes to agricultural productivity can have quite 
different impacts to changes in consumer demand for primary products. Increasing 
productivity results in greater total social welfare, which is divided amongst innovators, 
consumers, and producers. Innovators generally capture significant returns through 
appropriate licensing and pricing of biotechnological innovations (Falck-Zepeda et al., 
2000; Sobolevsky et al., 2002). Consumers usually benefit from increased production: 
they have more food and fibre for lower prices (Frisvold et al., 2003). There are 
exceptions to this generalisation that arise from negative consumer reactions to genetic 
modification (Lapan and Moschini, 2002). Producers may or may not benefit from 
technology that increases agricultural efficiency. The exact impacts depend on ownership 
of the technology, its distribution, and trade policies (Falck-Zepeda et al., 2000; 
Sobolevsky et al., 2002; Lapan and Moschini, 2002). By contrast, innovations that create 
primary products with enhanced consumer-oriented qualities lead to benefits across the 
board (Saunders and Cagatay, 2003). Innovators can capture returns from the premium 
products, consumers gain by having more desirable products, and producers benefit from 
higher prices. 
One tool for analysing trade impacts is a partial equilibrium (PE) model. PE 
frameworks are useful for quantifying the effects of changes in agricultural production. 
This is due to a number of factors, including the level of commodity disaggregation, the 
ease of traceability of interactions, the transparency of the results, the relatively small size 
of the models, and the low number of behavioural parameters and the methods used to 
obtain those parameters (Francois and Hall, 1997; Gaisford and Kerr, 2000; Roningen, 
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1997; van Beers and van den Bergh, 1996). An extensive programme of trade analysis for 
New Zealand has been conducted with the Lincoln Trade and Environment Model 
(LTEM), a PE model. The LTEM was initially used to simulate various scenarios relating 
to adoption of GM crops in NZ, including reduced costs of production, premiums for and 
against GM and bans for GM products in key markets Japan and the EU (Saunders and 
Cagatay, 2003, 2001). Further modelling work has found that for biotechnology to have 
positive impacts on revenues to the primary sector, New Zealand must be able to keep 
productivity benefits for itself and/or the GM product must attract a higher price in world 
markets (Saunders et al., 2003). 
Another tool for analysing trade impacts is a computable general equilibrium (CGE) 
model. These models, which can be much larger and more complex than PE models, 
quantify linkages between different parts of the economy. There have been some CGE 
modelling activities in the Australian context that have relevance to New Zealand. A 
Productivity Commission Report (Stone et al., 2002) used the Global Trade Analysis 
Project (GTAP) model (Hertel, 1997) to examine potential impacts of GM technology on 
Australia’s trade in non-wheat grains and oilseeds. The results of the three scenarios in 
this report demonstrated that very small absolute changes would occur in Australia’s 
import and export flows. Rather, regions with currently significant GM sectors, which did 
not include New Zealand, received the most substantial impacts to trade and income.  
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Empirical Methods and Data 
LTEM: The Trade Model 
For the present research, the preferred method of analysis is a PE model. The ability to 
considered commodities at a disaggregated level is a key consideration for modelling the 
impacts of the biotechnologies in this report. Furthermore, the relative ease and 
transparency of the modelling make the final impacts easy to understand and interpret. 
Linkages beyond the agricultural sector may be quantified with supplemental analysis, 
with such as with multipliers derived from input-output tables. 
The trade modelling framework is the Lincoln Trade and Environment Model 
(LTEM), an agricultural multi-country, multi-commodity trade model that uses a PE 
framework to analyse the impact of changes in agricultural productivity and domestic 
agricultural and trade policies. The model is based on VORSIM, which evolved from 
SWOPSIM and its associated trade-database used to conduct analyses during the 
Uruguay Round of General Agreement on Trade and Tariffs (GATT) negotiations 
(Roningen, 1986; Roningen et al., 1991). It has been used to analyse trade policies, 
climate change policies, and markets for organically grown and genetically modified 
products. 
The LTEM embodies all the advantages of PE trade models. An additional strength of 
the LTEM is its explicit modelling of the dairy sector at a disaggregated level. Dairy 
products are New Zealand’s largest single agricultural commodity, and nearly all the 
country’s production goes to export markets, making it the largest agricultural export. 
Because dairy markets are under the influence of various domestic and border policies, 
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explicit modelling of supply and demand behaviour is essential in order to quantify the 
impacts of productivity changes. 
The LTEM includes 19 agricultural commodities (seven crop and 12 livestock 
products) and 17 countries. The linkages of the agricultural sector with other industries 
and factor markets are not considered. The commodities included in the model are treated 
as homogeneous with respect to the country of origin and destination, and with respect to 
the physical characteristics of the product. Therefore commodities are assumed to be 
perfect substitutes in consumption in international markets. Importers and exporters are 
assumed to be indifferent about their trade partners.  
The LTEM is a synthetic model whose parameters are adopted from the relevant 
literature. Interdependencies between primary and processed products and between 
substitute or complementary products are reflected by cross-price elasticities. The model 
is then used to quantify the price, supply, demand and net trade effects of policy changes.  
The model is used to derive the medium- to long-term policy impact in a comparative 
static fashion. The base year the model works from is 2000. The present research models 
impacts up to 2005 to determine present price effects. 
In the general LTEM framework, there are seven endogenous variables in the 
structural-form of the equation set for a commodity under each country, made up of six 
behavioural equations and one economic identity. There are four exogenously determined 
variables, but the number of exogenous variables in the structural-form equation set for a 
commodity varies based on cross-price and cross-commodity relationships. The 
behavioural equations are: (i) domestic supply, (ii) demand, (iii) stocks, (iv) domestic 
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producer price, (v) consumer price, and (vi) trade price. The economic identity is a net 
trade equation, which is equal to excess supply or demand in the domestic economy. For 
some products, the number of behavioural equations may change as the total demand is 
disaggregated into food, feed, and processing industry demand. This is determined 
endogenously. 
 
Model inputs  
Research into commercialised applications of four biotechnologies across the whole 
primary sector, reported in Kaye-Blake et al. (2005), calculated the productivity impacts 
of novel products or applications. The data was collected through surveying key 
informants about the production impacts of the technology, the available alternatives to 
biotechnological innovations, and the rates at which innovations had been adopted by 
primary producers. It focused on four specific modern biotechnologies:  
• Clonal propagation/cell manipulation, 
• Bio-control agents, or bio-pesticides, 
• Enzyme manipulation, and 
• Marker-assisted selection or breeding. 
The major quantitative findings are given in table 1. The total net benefit of these 
innovations to the primary sector was estimated to be $266 million per year in 2005. The 
contribution of these biotechnologies to the different subsectors is apparent in these 
figures. Dairy production benefited the most from these innovations, which is not 
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surprising given that dairy production is the largest of the subsectors. Other pastoral 
agriculture also benefited, with impacts on sheep production larger than those on beef and 
veal production. The horticulture subsector showed significant benefits, with some crops 
heavily reliant on biotechnology and other barely affected. The dollar value of impacts in 
arable crops was relatively small, but this was a function of the size of the subsector. 
Finally, impacts were relatively small for forestry as only one of the biotechnologies had 
commercial application, and they were nil for seafood production. 
 
 
Table 1. Summary of direct impacts of four biotechnologies 
Subsector 
Value of clonal 
propagation / 
cell 
manipulation 
(NZ$000’s) 
Value of 
biocontrol 
agents 
(NZ$000’s) 
Value of 
enzyme 
manipulations 
(NZ$000’s) 
Value of 
marker 
assisted 
selection 
(NZ$000’s) 
Total 
(NZ$000’s)
Dairy 74,914 19,893 3,791 nil 98,598 
Beef and veal 20,890 772 nil nil 21,662 
Sheep (meat 
and wool) 35,287 41,353 nil 770 77,410 
Forestry 16,976 nil nil nil 16,976 
Horticulture and 
floriculture 32,995 small value 9,960 nil 42,955 
Arable crops 8,220 nil nil nil 8,220 
Seafood nil nil nil nil 0 
Total 189,282 62,018 13,751 770 265,821 
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The figures shown in table 1 contain an important assumption: that the changes in 
production had no impact on farmgate prices. Biotechnology was shown in Kaye-Blake et 
al. (2005) to increase the production of several important commodities, but no adjustment 
was made for possible price impacts. By incorporating the above figures into the LTEM, 
it is possible to estimate the price impacts associated with productivity gains. These 
prices changes can then be used to estimate the net impact on the agricultural sector. 
One key input into the trade model is the uptake rates of new technologies. A major 
factor affecting the aggregate impacts of an innovation on the primary sector is the 
proportion of producers who have adopted it. Uptake or adoption rates were not found to 
be uniform across innovations or across subsectors.  However, in the LTEM, the 
commodities produced are assumed to be homogenous. As a result, it is possible to 
express the aggregate impact of a biotechnology as a percentage of production. The 
production impact can be measured at the commodity level and then a single shift in 
production modelled for each commodity. Because of commodity homogeneity, the 
production impact is the same regardless of whether it is modelled as technology uptake 
by specific producers or simple commodity-wide productivity shifts. One drawback to 
this method, however, is that it cannot account for uneven impacts in the primary sector 
from uneven adoption of innovations. 
A second key input is the effects of biotechnology on the productivity of the primary 
sector. Three different scenarios were modelled. The first scenario is the base case, 
primary production as it currently happens. This is modelled by using the base data for 
2000 and modelling expected production up to 2005. No shifts in productivity are 
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modelled in the first scenario. The other two scenarios model production in New Zealand 
in the absence of the biotechnology-derived production shifts in table 1. This absence is 
modelled as a proportional reduction in primary sector productivity. The modelled 
production shifts are given in table 2. In this table, the negative signs indicate that 
production would be lower without biotechnology. Demand and supply equations in the 
LTEM are assumed to have constant elasticity functional form and exogenous shocks to 
this model arising from biotechnology are assumed to shift demand and supply by a 
constant percentage of price for all levels of production, so that pivotal shifts are 
assumed. These are similar to the shifts described in Frisvold et al. (2003) in their work 
on returns to technological advancements. 
The two alternative scenarios have one key difference. For the first one, the 
productivity reductions affect all countries: the innovations are removed from the primary 
sectors everywhere. This scenario examines the impact of an absence of biotechnology 
with the assumption that all countries have benefited equally from these innovations. For 
the second scenario, several of the innovations are removed from the primary sector only 
in New Zealand. This scenario is considered because of the New Zealand-specific 
application of some innovations. For example, some endophyte technology specific to 
New Zealand pasturage has been extensively adopted domestically, but less extensively 
adopted elsewhere. 
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Table 2. Productivity impacts for modelling 
Trade commodity Change in productivity 
Alternative scenario 1 
Production systems 
affected 
Alternative scenario 2 
Production systems 
affected 
Wheat - 5.1% All countries All countries 
Coarse grains - 5.1% All countries All countries 
Beef, veal - 1.9% All pastoral NZ only 
Sheepmeat - 3.9% All pastoral NZ only 
Wool - 3.9% All pastoral NZ only 
Milk, raw - 2.3% All pastoral NZ only 
Apples nil n/a n/a 
Kiwifruit nil n/a n/a 
 
Detailed modelling of the dairy complex is a key strength of the LTEM. In particular, 
the model separates production into extensive (e.g., pastoral) systems and intensive (e.g., 
feedlot) systems. This is an important distinction when modelling biotechnological 
innovations, because several innovations in use in New Zealand affect only pastoral 
systems. Feedlot production would not be improved by innovations in pasture quality. In 
order to reflect the differences among raw milk physical production systems in terms of 
the differences in nitrogen fertilizer and feed concentrates use, the countries Australia, 
EU, New Zealand and USA were separated into three regions and supply responses in 
these regions were modelled explicitly. 
The major dairy producing trading blocs were each sub-divided into regions (defined 
as in table 3) to reflect internal heterogeneity with respect to dairy production systems 
and environmental conditions. These divisions were based on observed variation in, for 
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example, yields, stocking rates and drainage characteristics as well as the nitrogen 
fertilizer and feed concentrate use. The divisions are incorporated into the LTEM through 
the regional domestic raw milk supply equations. Data on production systems were taken 
from a number of sources, including farm advisory recommendations, census and survey 
reports, and field trials. 
 
Table 3. Heterogeneity in the dairy production system amongst regions 
Region Production per cow (litres) 
Average 
stocking rate 
(per ha) 
Area 
(000ha) 
EU (15) :    
   West EU 5310 2.4 3174.8 
   East EU 4680 1.8 6639.6 
   Other EU 4991 2.3 3302.2 
Australia:    
   Victoria 4715 1.0 1267.9 
   NSW 4972 0.5 504.0 
   Rest of Australia 4608 0.5 1046.0 
USA: 7238   
   California 8439 10.0 149.2 
   WI, MI, MN, PA, NY 7182 3.0 1251.2 
   Rest of USA 6770 2.7 1727.8 
New Zealand:    
   Auckland 3278 2.8 494.6 
   South Island 3874 2.6 274.8 
   Rest of NZ 3300 2.0 570.4 
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The final key input is consumer willingness to pay for differentiated products, such as 
organically grown or genetically modified food. The LTEM can simulate different 
willingness to pay for segmented commodity products. For example, an enzyme 
biotechnology that produces superior meat characteristics could lead to higher export 
prices for adopting producers. This capability of the LTEM was not used for the 
modelling. For most commodities, there were no biotechnological innovations that 
altered product qualities and led to premium prices. For horticultural products, some 
innovations were identified that led to premium prices, but those products are not 
included in the LTEM. The main horticultural products in the model, apples and 
kiwifruit, were not affected by quality-enhancing biotechnologies. As a result, no demand 
shifts were modelled.  
 
Results 
Trade models by their nature produce a range of outputs: consumer and producer prices, 
quantities produced, quantities traded, and more. The information of importance here is 
the price change for each commodity as a result of lower production. For each 
commodity in the model whose production was affected by biotechnology, the difference 
in producer prices and quantities produced between production with biotechnology and 
production without biotechnology was calculated. The changes in both price and quantity 
were used to calculate the changes to gross producer returns. These calculations were 
made for both scenarios and are presented in table 4. 
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Table 4. Results of modelling 
Alternative scenario 1 
World-wide impacts 
Alternative scenario 2 
Some NZ-only impacts 
Trade 
commodity 
Change in 
productivity Change in NZ 
producer price 
(%) 
Change in 
NZ producer 
returns (%)
Change in NZ 
producer price 
(%) 
Change in 
NZ producer 
returns (%) 
Wheat - 5.1% 5.4 3.6 5.5 0.2 
Coarse grains - 5.1% 4.1 1.6 4.3 0.2 
Beef, veal - 1.9% 2.6 0.6 1.0 -2.0 
Sheepmeat - 3.9% 4.6 1.9 1.0 -6.3 
Wool - 3.9% 3.1 -0.6 1.0 -4.1 
Milk, raw - 2.3% 1.8 -1.2 1.1 -1.4 
 
The results for the first scenario indicate the impact on New Zealand producers had 
biotechnology not led to productivity gains anywhere in the world. When the impact of a 
worldwide reduction in productivity in the primary sector is modelled, market prices 
adjust upward in response to the reduction in supply. Trade also adapts to account for the 
change in productivity. As a result, the net change in producer returns for New Zealand is 
positive for wheat, coarse grains, beef and veal, and sheepmeat, and negative for wool 
and dairy. That is, higher prices and in some case higher quantities demanded lead to 
gains to arable crops, sheepmeat and beef (marginal). On the other hand, the higher price 
is not enough to offset the drop in production in the dairy sector, and producer returns 
fall. 
For Scenario 2, the price impacts are smaller for several commodities, those outside 
the arable crop subsector. These commodities were modelled as having improvements 
that applied only to the New Zealand primary sector, so that production in other countries 
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was unaffected. Thus, the absence of biotechnology in New Zealand alone has smaller 
price impacts on international commodity markets. The net impact on producer returns is 
essentially nil for wheat and coarse grains and negative for all other commodities. The 
reduction of New Zealand production and exports is enough to increase international 
prices slightly, but the rise is not sufficient to offset the losses in production. 
To calculate the dollar value of these impacts, data on the revenues for these 
commodities was adjusted to account for the results from the trade modelling. The gross 
margins were then calculated to make the results comparable to the net impacts shown in 
table 1. Table 5 presents the results for the first alternative scenario, and table 6 presents 
those for the second. For these calculations, changes to forestry, horticulture, and seafood 
are not included, as they are not part of the trade model. 
The net, price-adjusted direct economic impact as calculated in table 5 was the 
reduction in producer returns (after variable costs) that arose from an absence of 
biotechnologies. This result suggests that by using the biotechnological innovations 
identified in this research, and assuming that all other countries had access to the same 
technology, the New Zealand primary sector had a direct economic benefit of $19 million 
dollars, excluding forestry and horticulture. By contrast, the direct economic benefit, 
without accounting for price shifts, for these subsectors was calculated shown in table 1 
to be $206 million. 
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Table 5. Alternative scenario 1: impact of absence of biotechnologies 
Subsector 
Revenues with 
biotechnology 
($000’s) a 
Change in 
producer 
returns 
(%) 
Change in 
producer returns
($000’s) 
Gross margin 
($ per dollar of 
revenue) b 
Net impact of 
absence of 
biotechnology 
($000’s) 
Dairy 5,312,500 -1.2 -64,169 0.79 -50,694 
Beef and veal 1,300,320 0.6 7,539 0.90 6,785 
Sheep (meat and 
wool) c 2,824,090 1.1 29,827 0.70 20,879 
Arable crops d 364,187 2.2 7,856 0.45 3,535 
Total     -19,494 
a Kaye-Blake et al., 2005; Ministry of Agriculture and Forestry, 2004; Statistics New Zealand, 
2004. 
b Burtt, 2004; Kaye-Blake et al., 2005. 
c The change in producer returns is calculated as the average of the Sheepmeat and Wool impacts 
in table 4, weighted by the amount of revenue in Lamb, Mutton and Wool in (Ministry of 
Agriculture and Forestry, 2004). 
d The change in producer returns is calculated as the average of the Wheat and Coarse grains 
change in producer returns in table 4, weighted by the amount of revenue for each arable crop as 
shown in (Kaye-Blake et al., 2005).  
 
The value calculated in table 6 indicates how much lower direct economic impacts in 
the primary sector would be in the absence of specific biotechnologies. These are New 
Zealand-specific biotechnologies that increase the productivity of the pasture-based parts 
of the primary sector. In this scenario, some biotechnologies, such as those in arable 
crops, were simply not available worldwide. Other biotechnologies were removed only 
from New Zealand commodity production. These were biotechnological innovations in 
dairy, meat and wool production. The reduction in direct impacts was $191 million, 
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which was very nearly identical to the direct economic benefit for these subsectors in 
table 1, $206 million. 
 
Table 6. Scenario 2: impact of absence of NZ biotechnologies* 
Subsector 
Revenues with 
biotechnology 
($000’s) 
Change in 
producer 
returns 
(%) 
Change in 
producer returns
($000’s) 
Gross margin 
($ per dollar of 
revenue) 
Net impact of 
absence of 
biotechnology 
($000’s) 
Dairy 5,312,500 -1.4 -73,774 0.79 -58,281 
Beef and veal 1,300,320 -2.0 -25,911 0.9 -23,320 
Sheep (meat and 
wool) 2,824,090 -5.5 -156,377 0.7 -109,464 
Arable crops 364,187 0.2 707 0.45 318 
Total     -190,747 
* See notes from table 5. 
 
Discussion of modelling results 
The results from the trade analysis provide important information regarding the impacts 
of biotechnology. The two alternative scenarios modelled present two different pictures 
of biotechnology in New Zealand. The first alternative models the primary sector without 
the innovations based on the four biotechnologies mentioned above. Many examples of 
these biotechnologies, particularly those that are clonal or cell technologies, are widely 
used. If these biotechnologies had not been developed, then they would not have affected 
production anywhere in the world. The difference between the world with biotechnology, 
the base case, and the world without the identified innovations, is measured by the first 
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alternative. For those sectors in the LTEM, considering the combination of price and 
quantity effects, the difference between using and not using biotechnology in New 
Zealand is $19 million in direct economic impacts. This is about 9.2% of the calculated 
impacts that do not account for price shifts (table 1). This result suggests that New 
Zealand gains little from the worldwide use of these biotechnologies, because the price 
decreases nearly cancel out the increased quantity from productivity gains. 
The second scenario is slightly different. For this modelling, dairy, meat and wool 
productivity were reduced only in New Zealand (arable crop productivity was reduced for 
all countries). The second scenario considers a world in which biotechnological 
innovations with application specifically to New Zealand environments had not been 
developed. Without these innovations boosting New Zealand production, the primary 
sector would lose direct economic impacts of $191 million. This figure is about 92.7% of 
the constant-price calculations, suggesting that innovations that are specific to New 
Zealand do contribute significantly to agricultural sector revenues. 
The trade model can also provide results for each subsector. For dairy products, loss of 
biotechnology reduced producer revenues for both alternative scenarios. New Zealand’s 
dairy industry clearly gains from biotechnology, whether it is adopted just in New 
Zealand or more globally. For the meat subsectors, the results of the two alternatives are 
rather different. The results for beef and veal suggest that worldwide loss of 
biotechnology does not have much impact on New Zealand, but the sheepmeat sector 
would have greater revenues with lower productivity. However, both sectors are smaller 
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with the loss of New Zealand-specific innovations, with sheepmeat having the highest 
impact of any subsector.  
The differences in impacts across subsectors suggest that the economic impacts of 
biotechnology on New Zealand, a small, open economy, are affected by the markets with 
which the country trades. Productivity gains by themselves are not the whole story. Issues 
like market structure, trade policies, and domestic production in overseas markets, which 
are captured by using a trade model, all affect the net economic impact from innovations. 
The results, taken together, also suggest that biotechnology is another element in an 
agricultural technology treadmill. Early adoption of innovations can lead to economic 
gains, but once those adoptions are widespread the gains to the agricultural sector are 
small. However, if the innovations are not available to or not adopted by a specific 
country, then its agricultural sector could face large losses as its competitors become 
more efficient.  
  
Conclusion 
This trade modelling contributes to the literature on biotechnology. Most research on the 
trade impacts of biotechnology has had to rely on ad hoc assumptions regarding 
productivity impacts due to lack of data. The present research has used data on actual 
productivity impacts of commercialised biotechnology products in New Zealand. These 
impacts were then incorporated into a model of international trade. This analysis of trade 
impacts thus provides an analysis of what has actually occurred in New Zealand 
agriculture. 
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The analysis demonstrates the net impact of changing productivity. The data from 
Kaye-Blake et al. (2005) assumed that the price elasticity of demand for agricultural 
commodities was practically infinite: the New Zealand primary sector was a price-taker 
on world commodity markets, too small to make a difference. The trade analysis makes 
some adjustment to this picture. By considering the impact that New Zealand can have on 
commodity markets, especially in dairy products and meat, it provided a different result 
and indicated differences amongst subsectors. 
Which of the two alternative scenarios more accurately portrays the New Zealand 
situation is uncertain. Clearly, adopting biotechnology is important. It increases 
productivity, which either allows New Zealand to have a competitive advantage in certain 
commodities or keeps the country in line with its rivals. If the former is true, that is, if 
biotechnology research has produced innovations that preferentially benefit New 
Zealand, then the contribution of biotechnology is closer to the absolute value of the 
estimate in the second alternative. In this case, the New Zealand agricultural sector may 
be about NZ$200 million larger because of these biotechnologies. If the latter is true, then 
the net impact on producer returns from using these biotechnologies, given that everyone 
else has adopted similar innovations, too, is closer to the estimate in the first alternative. 
The net gain to New Zealand agriculture in that case may be more on the order of NZ$20 
million. 
This research has also suggested areas for further investigation. Because this trade 
model assumes commodities are homogeneous, the impacts on different producers of the 
same commodity were not estimated. With uneven uptake of innovations, differences 
  21 
within a subsector would be expected. These differences could be analysed with a more 
disaggregated model. A second area not explored here was the impact of quality changes 
that affect consumers’ willingness to pay for commodities. Price differentials based on 
specific quality enhancements would be an important area for future research, in 
particular if they could be modelled alongside productivity changes. 
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Appendix 
The Trade Model 
This appendix provides a brief description of the Lincoln Trade and Environment Model 
(LTEM). Included in this description are the equations in the model and the method of 
determining prices and quantities. 
Each country in the LTEM has its own set of behavioural equations for each 
commodity. In general there are six behavioural equations and one economic identity for 
each commodity in each country, i.e. there are seven endogenous variables in the 
structural-form of the equation set. These behavioural equations are domestic supply, 
demand, stocks, domestic producer and consumer prices and a trade price equation. The 
economic identity is the net trade equation, representing the excess supply or demand in 
each country. There is some variation between countries and commodities based on the 
levels of disaggregation. The following section explains the functional form and variable 
specification for the behavioural equations.   
 
Domestic Supply 
The type of supply equation used in the LTEM is known as a directly estimated partial 
supply response model (Colman, 1983). The equation is a function of own- and cross-
prices, with an ad hoc theoretical background. The equations use the Cobb-Douglas (CD) 
constant elasticity functional form, specified at the level of the variables. The general 
form of the supply equations for the commodities is presented below: 
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∏=
j
jtitit
jppppqs ααα 10
;   01 >α , 0<jα   
where: 
i = own commodity 
j = substitutes  
qs = domestic supply  
pp = producer price 
t = time period. 
 
Domestic Demand 
Demand is simulated in the LTEM using a uniform CD aggregate domestic demand 
function, again for each country and commodity. The demand relationship is derived 
from the consumers’ utility maximisation behaviour under perfect competition 
assumption. Demand is therefore specified as a function of the own- and substitute prices, 
per capita income and the population growth rate. Income and population are exogenous 
to the model. The general form of the demand equations is: 
j
j
jtttitfoti pcpoppincpcqd
βββββ ∏= 3210,
; 01 <β , 02 >β , 03 >β , 0>jβ   
qj
qt
j q
jtitfeti qspcpcqd
ββββ ∏∏= 10,
;  01 <β , 0>jβ , 0>qβ    
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where: 
pc = consumer price 
pinc = per capita income 
pop = population 
qdfe = domestic feed demand 
qdfo = domestic food demand 
 
Stocks 
Stocks are modelled using the theory of inventory demand (FAPRI, 1989). The main 
motive for the stock demand is transaction rather than speculation. The equations are 
shown below: 
1
0
ϕϕ itit qsqe = ;    01 >ϕ  
1ϕϕ itiit qdqe = ;    01 >ϕ  
where: 
qd = domestic demand (can be food, feed or processing) 
qe = stocks 
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Net Trade 
As mentioned previously, net trade in the LTEM is an economic identity based on the 
difference between domestic supply and the sum of various demand amounts as well as 
stocks. Stocks are incorporated as a change from the previous year. The net trade 
equation is shown below: 
)()( ,,, itprtifetifotiitit qeqdqdqdqsqt ∆−++−=   
where: 
qt = quantity traded 
qdpr = quantity processed 
Raw milk is not traded as its supply is assumed to be completely exhausted in the 
production of the other dairy products.   
 
Prices 
Domestic consumer and producer prices in the LTEM are determined by the world trade 
prices for each commodity, as well as the domestic and border policies applied in each 
country. Equations 19 and 20 illustrate this price transmission mechanism. The trade 
price of a commodity is determined by the world market price of that commodity, as 
shown in equation 18. Producer and consumer support and subsidy measures are 
incorporated into the price equations through the use of commodity based price wedge 
variables, which differentiate the domestic and trade prices of each commodity. These 
variables may include per unit direct payments, inputs subsidies, general services 
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expenditures and other market subsidy payments to producers, as well as a consumer 
market subsidy, as shown in equations 21 and 22. These policies are all calculated per 
tonne of production and consumption, following the concept of producer and consumer 
subsidy equivalents (PSE and CSEs) (Cahill and Legg, 1990). 
τε
⎟⎠
⎞⎜⎝
⎛=
ex
WDppt itit
         
tpptpp += ttc+  ;   0=tc    ititit
tititit tctcptpc ++=  ;   0=tc    
mstpptpp )( ititititititit ssgsid +++++=      
       
where: 
nsumer market subsidy 
xpenditure 
r market subsidy 
itititit cmtcptpc ++=   
cm = co
ex = exchange rate 
pt = trade price  
sd = direct payments 
sg = general services e
si = input subsidy 
sm = other produce
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tci = export subsidies 
tc = transportation costs 
tpi = import tariffs 
WDp = world price 
The model works by simulating the commodity-based clearing price in world markets 
on the domestic quantities and prices, which may or may not be under the effect of policy 
changes, in each country. Excess domestic supply or demand in each country spills over 
onto the world market to determine world prices. The world market-clearing price is 
determined at the level that equilibrates the total excess demand and supply of each 
commodity in the world market, by using a non-linear optimisation algorithm (Newton’s 
global or search algorithm). 
All prices in the LTEM are in US dollars, removing any exchange rate effects. 
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